Your browser doesn't support javascript.
loading
Botulinum Toxin Treatment of Spasticity in Adults and Children.
Moeini-Naghani, Iman; Hashemi-Zonouz, Taraneh; Jabbari, Bahman.
Afiliación
  • Moeini-Naghani I; Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
  • Hashemi-Zonouz T; Department of Diagnostic radiology, Yale University School of Medicine, New Haven, Connecticut.
  • Jabbari B; Department of Neurology, Yale University School of Medicine, New Haven, Connecticut.
Semin Neurol ; 36(1): 64-72, 2016 Feb.
Article en En | MEDLINE | ID: mdl-26866498
Spasticity is a frequent symptom in stroke, multiple sclerosis, cerebral or spinal trauma, and cerebral palsy that affects and disables a large number of adults and children. In this review, we discuss the pathophysiology and nonpharmacologic and pharmacologic treatments of spasticity with emphasis on the role of botulinum neurotoxins (BoNTs). The world literature is reviewed on double-blind and placebo-controlled clinical trials reporting safety and efficacy of BoNT treatment in adult spasticity and spasticity of children with cerebral palsy. The evidence for efficacy is presented from recommendations of the Assessment and Therapeutics subcommittee of the American Academy of Neurology. A technical section describes the techniques and recommended doses of BoNTs in spasticity.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Botulínicas / Espasticidad Muscular Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child / Humans Idioma: En Revista: Semin Neurol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Toxinas Botulínicas / Espasticidad Muscular Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Child / Humans Idioma: En Revista: Semin Neurol Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos